References
- Kota SK , FeilR. Epigenetic transitions in germ cell development and meiosis. Dev. Cell19(5) , 675–686 (2010).
- Borgel J , GuibertS, LiY et al. Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 42(12) , 1093–1100 (2010).
- Berdasco M , EstellerM. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell19(5) , 698–711 (2010).
- O‘Hagan HM , WangW, SenS et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and Polycomb members to promoter CpG islands. Cancer Cell 20(5) , 606–619 (2011).
- Sawarkar R , ParoR. Interpretation of developmental signaling at chromatin: the Polycomb perspective. Dev. Cell19(5) , 651–661 (2010).
- Berman BP , WeisenbergerDJ, AmanJF et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat. Genet. 44(1) , 40–46 (2011).
References
- Esteller M . Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet.8 , 286–298 (2007).
- Lima SC , Hernandez-VargasH, HercegZ. Epigenetic signatures in cancer: implications for the control of cancer in the clinic. Curr. Opin. Mol. Ther.12 , 316–324 (2010).
- Jones PA , BaylinAB. The epigenomics of cancer. Cell128 , 683–692 (2007).
- Jemal A , CenterMM, DeSantisC, WardEM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev.19 , 1893–1907 (2010).
- Balassiano K , LimaS, JenabM et al. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Letters 311 , 85–95 (2011).